Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Boni Theresa — Surface Oncology, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Boni Theresa

Boni Theresa

General Counsel & Secretary at Surface Oncology, Inc. · on record since Mar 18, 2022

Insider trading activity of Boni Theresa

Transactions on record: 1; since Apr 1, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 1, 2022

Figures computed from official regulatory filings — methodology.

Companies where Boni Theresa has traded

Surface Oncology, Inc.1 tx · Apr 1, 2022

Track record of Boni Theresa

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Boni Theresa

Co-insiders of Boni Theresa

Adams ChandraSurface Oncology, Inc.
Atlas Venture Associates IX, LLCSurface Oncology, Inc.
Atlas Venture Associates IX, L.P.Surface Oncology, Inc.
Atlas Venture Fund IX, L.P.Surface Oncology, Inc.
BARRETT M JAMESSurface Oncology, Inc.
BARRIS PETER JSurface Oncology, Inc.
BASKETT FORESTSurface Oncology, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Brunn CarstenSurface Oncology, Inc.

Chappel Scott CSurface Oncology, Inc.

Dwyer WendySurface Oncology, Inc.

EcoR1 Capital, LLCSurface Oncology, Inc.

FEES JESSICASurface Oncology, Inc.

FIL LtdSurface Oncology, Inc.

Florence Anthony A. Jr.Surface Oncology, Inc.

FMR LLCSurface Oncology, Inc.

Goater JeffSurface Oncology, Inc.

GRAYZEL DAVID S.Surface Oncology, Inc.

Hall Steven EdwardSurface Oncology, Inc.

Hickey BenjaminSurface Oncology, Inc.

Ibrahim RamySurface Oncology, Inc.

Kearney Michael JSurface Oncology, Inc.

KERINS PATRICK JSurface Oncology, Inc.

Lilly Ventures Fund I LLCSurface Oncology, Inc.

LV Management Group, LLCSurface Oncology, Inc.

LYNCH DANIELSurface Oncology, Inc.

MCDONOUGH GEOFFSurface Oncology, Inc.

MOTT DAVID MSurface Oncology, Inc.

NEA 14 GP, LTDSurface Oncology, Inc.

NEA Partners 14, L.P.Surface Oncology, Inc.

New Enterprise Associates 14, L.P.Surface Oncology, Inc.

Nogelo Liisa ISurface Oncology, Inc.

NOVARTIS AGSurface Oncology, Inc.

Novartis Institutes for BioMedical Research, Inc.Surface Oncology, Inc.

October 2017 Liquidating TrustSurface Oncology, Inc.

ONEILL ALISONSurface Oncology, Inc.

Palombella Vito J.Surface Oncology, Inc.

RATH HENRY C.Surface Oncology, Inc.

ROSS ROBERT W.Surface Oncology, Inc.

SANDELL SCOTT DSurface Oncology, Inc.

Shanafelt ArmenSurface Oncology, Inc.

Sigal Charles ElliottSurface Oncology, Inc.

Sonsini Peter W.Surface Oncology, Inc.

Stelzer LaurieSurface Oncology, Inc.

Torres DeniceSurface Oncology, Inc.

Torres S. EdwardSurface Oncology, Inc.

Viswanathan RaviSurface Oncology, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Surface Oncology, Inc.	Apr 1, 2022	AwardD	120,000	0.00 USD	$0	SEC